PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES

Detalles Bibliográficos
Autores principales: Gao, X.-N., Lou, X., Lin, J., Su, Y.-F., Wang, J., Xu, L., Yu, H., Wang, A., Wang, Y.-Z., Liu, D.-H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429015/
http://dx.doi.org/10.1097/01.HS9.0000850136.22948.60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429015/
http://dx.doi.org/10.1097/01.HS9.0000850136.22948.60

Ejemplares similares